Improved Stabilities of Labeling Probes for the Selective Modification of Endogenous Proteins in Living Cells and In Vivo

To date, various affinity-based protein labeling probes have been developed and applied in biological research to modify endogenous proteins in cell lysates and on the cell surface. However, the reactive groups on the labeling probes are also the cause of probe instability and nonselective labeling in a more complex environment, e. g., intracellular and in vivo. Here, we show that labeling probes composed of a sterically stabilized difluorophenyl pivalate can achieve efficient and selective labeling of endogenous proteins on the cell surface, inside living cells and in vivo. As compared with the existing protein labeling probes, probes with the difluorophenyl pivalate exhibit several advantages, including long-term stability in stock solutions, resistance to enzymatic hydrolysis and can be customized easily with diverse fluorophores and protein ligands. With this probe design, endogenous hypoxia biomarker in living cells and nude mice were successfully labeled and validated by in vivo, ex vivo, and immunohistochemistry imaging.     

Trehalose-protected lipid membranes for determining membrane protein structure and insertion

Trehalose preserves lipid bilayers during dehydration and rehydration by replacing water to form hydrogen bonds between its own OH groups and lipid headgroups. We compare the lipid conformation and dynamics between trehalose-protected lyophilized membranes and hydrated membranes, to assess the suitability of the trehalose-containing membrane as a matrix for membrane protein structure determination. (31)P spectra indicate that the lipid headgroup of trehalose-protected dry POPC membrane (TRE-POPC) have an effective phase transition temperature that is approximately 50K higher than that of the hydrated POPC membrane. In contrast, the acyl chains have similar transition temperatures in the two membranes. Intramolecular lipid (13)C'-(31)P distances are the same in TRE-POPC and crystalline POPC, indicating that the lipid headgroup and glycerol backbone conformation is unaffected by trehalose incorporation. Intermolecular (13)C-(31)P distances between a membrane peptide and the lipid headgroups are 10% longer in the hydrated membrane at 226 K than in the trehalose-protected dry membrane at 253 K. This is attributed to residual motions in the hydrated membrane, manifested by the reduced (31)P chemical shift anisotropy, even at the low temperature of 226 K. Thus, trehalose lyoprotection facilitates the study of membrane protein structure by allowing experiments to be conducted at higher temperatures than possible with the hydrated membranes.     

分子筛膜反应器的研究进展

分子筛膜具有规整的微孔结构(<1 nm), 耐高温高压、 抗有机溶剂, 在液相和气相小分子分离中受到广泛关注. 分子筛膜可以与催化反应耦合于一体构成膜反应器, 使反应过程与组分分离同时进行, 促进反应平衡移动, 达到反应强化的效果. 本文概述了近十年不同类型分子筛膜反应器在催化反应中的应用研究进展, 并对分子筛膜反应器未来的发展趋势进行了展望.     

微纳米纤维素功能膜在能源与环境领域的应用

探寻绿色清洁的资源与材料以维持高效的社会经济增长是未来数十年人们面临的最大挑战之一. 可持续资源与绿色材料的开发是降低传统化石能源与材料比重的最有前途的方案. 纤维素作为一种可持续发展、 可生物再生、 储量丰富且低成本的天然高分子聚合物, 在众多领域中具有广泛的应用, 并且纤维素可以加工成各种构型, 包括气凝胶、 泡沫、 海绵和薄膜等. 本文介绍了不同形态的纤维素及其衍生物组装而成的功能膜在能源与环境中的应用, 综述了微纳米纤维素及其衍生物在先进功能化储能器件方面的最新进展和制备方案, 以及在用于水处理的膜分离技术中的应用, 其中重点讨论了微纳米纤维素及其衍生物功能膜在电池、 电容器及水处理等领域中的作用, 如隔膜、 柔性电极膜和分离膜等. 此外, 还对纤维素及其衍生物功能膜的未来发展进行了总结和展望.     

二氧化锰纳米管模拟氧化酶的性能、抑制剂及其对Pb2+的测定

采用简便的水热法,获得了具有氧化酶催化特性的二氧化锰纳米管,研究了其对氧气(O2)氧化3,3',5,5'-四甲基联苯二胺(TMB)发生显色反应的催化性能,重点考察了常见金属离子对其活性的抑制作用。结果表明,能与MnO2表面发生特异性吸附络合作用的Pb2+的抑制作用最为显著。基于该抑制作用,建立了针对铅离子的高灵敏、快速检测新方法。结果显示,铅的线性范围为1.0×10-7~1.0×10-3 mol/L,检出限为3.0×10-8 mol/L。     

壳聚糖混合膜酶降解的FTIR分析

生物可降解性是壳聚糖的重要性质之一,但利用傅里叶变换红外光谱(FTIR)研究降解过程中壳聚糖的变化则较少。文章制备了由高脱乙酰度壳聚糖(HDC)和中脱乙酰度壳聚糖(MDC)组成的混合膜。运用FTIR分析了壳聚糖混合膜组分变化对其红外谱图和脱乙酰度(DD)的影响,并研究了该混合膜在溶菌酶的降解作用下红外谱图和脱乙酰度的变化。发现壳聚糖混合膜材料的脱乙酰度与膜中MDC组分的比例呈线性关系;随降解的进行,混合膜的脱乙酰度增加。结果证实了溶菌酶对较低脱乙酰度壳聚糖的选择性降解作用,而且表明FTIR可用于分析壳聚糖混合膜降解过程中的化学变化。     

Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification

Uniformly sized microparticles of poly(d,l-lactic-co-glycolic) (PLGA) acid, with controllable median diameters within the size range 40–140 μm, were successfully prepared by membrane emulsification of an oil phase injected into an aqueous phase, followed by solvent removal. Initially, simple particles were produced as an oil in water emulsion, where dichloromethane (DCM) and PLGA were the oil phase and water with stabiliser was the continuous phase. The oil was injected into the aqueous phase through an array type microporous membrane, which has very regular pores equally spaced apart, and two different pore sizes were used: 20 and 40 μm in diameter. Shear was provided at the membrane surface, causing the drops to detach, by a simple paddle stirrer rotating above the membrane. Further tests involved the production of a primary water in oil emulsion, using a mechanical homogeniser, which was then subsequently injected into a water phase through the microporous membrane to form a water in oil in water emulsion. These tests used a water-soluble model drug (blue dextran) and encapsulation efficiencies of up to 100% were obtained for concentrations of 15% PLGA dissolved in the DCM and injected through a 40 μm membrane.

Solidification of the PLGA particles was followed by removal of the DCM through the surrounding aqueous continuous phase. Different PLGA concentrations, particle size and osmotic pressures were considered in order to find their effect on encapsulation efficiency. Osmotic pressure was varied by changing the salt concentration in the external aqueous phase whilst maintaining a constant internal aqueous phase salt concentration. Osmotic pressure was found to be a significant factor on the resulting particle structure, for the tests conducted at lower PLGA concentrations (10% and 5% PLGA). The PLGA concentration and particle size distribution influence the time to complete the solidification stage and a slow solidification, formed by stirring gently overnight, provided the most monosized particles and highest encapsulation efficiency.     

膜去溶进样高分辨电感耦合等离子体质谱法测定半导体级氢氟酸中杂质元素

利用高分辨电感耦合等离子体质谱法测定半导体级高纯氢氟酸中的痕量金属杂质,用膜去溶进样系统直接进样检测,无需前处理、快速,避免了在样品前处理时的污染问题。高分辨电感耦合等离子体质谱法可以消除多分子离子干扰,降低检出限,提高定量准确性。方法的检出限为0.09～37.07ng/L,加标回收率为92.3%～116.8%。方法简单,结果可靠,适用于高纯氢氟酸中痕量元素的快速测定。     

PLA/MSM缓释微球的制备及生物活性

采用膜乳化-液中干燥法制备出担载二甲基砜(MSM)的聚乳酸(PLA)微球(PLA/MSM), 并研究了膜孔径、 搅拌转速和MSM浓度对载药微球形貌、 尺寸、 载药量、 体外释放及细胞活性的影响; 采用场发射环境扫描电子显微镜(ESEM)观察微球形貌、 尺寸及分布, 用等离子体发射光谱(ICP-AES)法检测PLA/MSM微球载药量、 包封率及体外释放, 采用ESEM观察微球内部结构, 并通过体外细胞培养和噻唑蓝(MTT)法检测MC-3T3-E1细胞的增殖能力. 研究结果表明, 膜乳化法制备的载药微球规整, 呈典型的圆球状, 表面光滑, 内部有多孔结构. 当膜孔径为5.1 μm且搅拌转速为500 r/min时, PLA/MSM微球大小更为均一; 当体系中MSM质量分数为8.6%时, 载药量可达到77.43%. 随着膜孔径减小及药物浓度的增加, 体外释放速率加快, 但初期均无明显的突释现象, 约10 d后累积释放量达到89.2%. 细胞实验结果显示, 在膜孔径为5.1 μm且MSM质量分数为8.6%的条件下, 制备的载药微球在细胞培养7 d时表现出明显的促增殖作用.